Wednesday 31 May 2017

AUROBINDO PHARMA: Better off compared to peers; positive outlook for FY18 says Motilal Oswal https://goo.gl/5jJDXT


AUROBINDO PHARMA: Better off compared to peers; positive outlook for FY18 says Motilal Oswal https://goo.gl/5jJDXT
https://goo.gl/5jJDXT
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)